期刊文献+

MDSC的功能研究进展与应用前景 被引量:4

Research advancements and application prospect of myeloid-derived suppressor cells
原文传递
导出
摘要 髓源性抑制细胞(myeloid-derived suppressorcells,MDSC)是近年广泛研究的具有免疫抑制功能的细胞群,其来源于骨髓祖细胞和未成熟髓系细胞,在肿瘤、感染、自身免疫性疾病中呈现募集活化,参与免疫逃逸、免疫耐受、炎性反应等病理过程。因此,作为重要的免疫负调控细胞群体,MD-SC在多种疾病中的作用正日益受到关注, Myeloid-derived suppressor cells(MDSC) originate from the immature myeloid cells in bone mar row. MDSC act as a heterogeneie immunoregulatory population which can expand in response to many pathologica conditions. MDSC can aggravate the development and growth of tumor. Hence, MDSC may become novel therapeu tic targets of many diseases.
出处 《临床血液学杂志》 CAS 2013年第3期348-352,共5页 Journal of Clinical Hematology
基金 国家自然科学基金(No:81170472) 卫生公益性行业科研专项经费项(No:201202017) 天津市科技计划项目抗癌重大科技专项(No:12ZCDZSY17900)
关键词 髓源性抑制细胞 免疫抑制 靶向治疗 myeloid-derived suppressor cells(MDSC) immunosuppression targeted therapy
  • 相关文献

参考文献44

  • 1YOUN J UNAGGARAJ S,COLLAZO M.et al. Sub-sets of myeloid-derived suppressor cells in tumor-bearing mice[J]. J Immunol,2008.181:5791 — 5802.
  • 2KO J S,BUKOWSKI R M,FINEKE J H. MyeloicWe-rived suppressor cells : a novel therapeutic target [J].Curt Oncol Rep, 2009,11:87 —93.
  • 3SCHMIELAU J , FINN O J. Activated granulocytesand granulocyte-derived hydrogen peroxide are the un-derlying mechanism of suppression of T-cell functionin advanced cancer patients[J]. Cancer Res,2001,61:4756-4760.
  • 4FENG P H, LEE K Y, CHANG Y L,et al. CD14+S100A9+ monocytic myeloid-derived suppressor cellsand their clinical relevance in non-small cell lung canc-er[J]. Am J Respir Crit Care Med, 2012,186 : 1025 —1036.
  • 5DUFFY A,ZHAO F,HAILE L, et al. Comparative a-nalysis of monocytic and granulocytic myeloid-derivedsuppressor cell subsets in patients with gastrointesti-nal malignancies [ J Cancer Immunol Immunother,2012,62:299-307.
  • 6GABRILOVICH D I, NAGARAJ S. Myeloid-derivedsuppressor cells as regulators of the immune system[J]. Nat Rev Immunol,2009,9 :162 _174.
  • 7KOIKE Y,KANAI T, SAEKI K, et al. MyD88-de-pendent interleukin-10 production from regulatoryCD11 b( + ) GR-1 (high) cells suppresses developmentof acute cerulein pancreatitis in mice [ J ]. ImmunolLett,2012,148:172-177.
  • 8WU T,SUN C,CHEN Z, et al. Smad3-DeficientCD1 lb' Grl+ myeloid-derived suppressor cells pre~vent allograft rejection via the nitric oxide pathway[J]. J Immunol,2012,189:4989 — 5000.
  • 9ZHANG Y,UU Q,ZHANG M,et al. Fas signal pro-motes lung cancer growth by recruiting myeloid-de-rived suppressor cells via cancer cell-derived PGE2[J]. J Imnmnol,2009,182 :3801 — 3808.
  • 10ZHAO X,RONG L,ZHAO X,et al. TNF signalingdrives myeloid-derived suppressor cell accumulation[J]. J Clin Invest,20l2,122 :4094-4104.

同被引文献28

  • 1WS299-2008乙型病毒性肝炎诊断标准[S].2009-6-15.
  • 2Dolcetti L, Marigold I, Mantel B, et al. Myeloid-derived suppres- sor cell role in tumor-related inflammation[J]. Cancer Lett, 2008, 267(2) : 216-225.
  • 3Viguier M, Lemax~tre F, Verola O, et al. Foxp3 expressing CIM + CD25 (high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells [ J ]. J Immunol, 2004, 173 (2) : 1444-1453.
  • 4Srivastava MK, Sinha P, Clements VK, et al. Myeloid- derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine[ J]. Cancer Res, 2010, 70 (1) : 68-77.
  • 5Edge S, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual[ M]. 7th ed. New York: Springer, 2010: 117-126.
  • 6Zou W. Immunosuppressive networks in the tumour environment and their therapeutic relevance [ J ]. Nat Rev Cancer, 2005, 5 (4) : 263-274.
  • 7Bhardwaj N. Harnessing the immune system to treat cancer [J]. J Clin Invest, 2007, 117 (5) : 1130-1136.
  • 8Ohkura N, Hamaguchi M, Sakaguchi S. FOXP3 + regulatory T cells: control of FOXP3 expression by pharmacological agents [ J]. Trends Pharmacol Sci, 2011, 32 (3) : 158-166.
  • 9Cao X, Cai SF, Fehniger TA, et al. Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance [ J ]. Immunity, 2007, 27 (4) : 635-646.
  • 10Boissonnas A, Seholer-Dahirel A, Simon-Blaneal V, et al. Foxp3 + T cells induce perforin-dependent dendritic cell death in tumor-draining lymph nodes [ J ]. Immunity, 2010, 32 (2): 266-278.

引证文献4

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部